| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks
4 companies
Hoover R David is a Director at BALL, with reported holdings spanning 4 companies. Recent filings cover 38 purchases and 1 sale. Those positions are worth an estimated $117.6M at current prices.
Our model assigns Hoover R David a middling insider score of 50/100, based on 14 past trades. Over a 12-month horizon, 28.6% of those trades were profitable, with an average 12-month return of -13.3%.
Hoover R David's largest disclosed position is in BALL as Director, worth about $68.8M. The recent filings there lean toward selling, a net 2,200 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2018 | ELAN Elanco Animal Health Inc | Director | Buy | 10,000 | $24.00 | $240,000.00 | New | |
| Mar 8, 2018 | BALL Ball Corp | Director | Sale+OE | 2,200 | $40.71 | $89,562.00 | -1.1% | |
| Mar 6, 2018 | EPC Edgewell Personal Care Co | Director | Buy | 1,000 | $52.94 | $52,937.80 | +12.7% | |
| Feb 15, 2018 | EPC Edgewell Personal Care Co | Director | Buy | 1,000 | $54.78 | $54,781.80 | +14.5% | |
| Dec 16, 2016 | LLY Eli Lilly & Co | Director | Buy | 500 | $71.85 | $35,925.00 | +50.0% |